<p>(<b>A</b>) Quantification of the cell cycle profiles of control and <i>Rplp1<sup>i</sup></i><sup>Δ</sup> pMEFs that were untreated or treated for 4 days with 4-OHT. Student's t-test was applied for the statistical analysis. n.s.: not significant. Error bars: SEM. N = 3. (<b>B</b>) <i>Rplp1</i><sup>iΔ</sup> and control pMEFs were treated with 1 µM 4-OHT for 4 days or left untreated. The cells were harvested, stained with Annexin V/DAPI and analyzed by flow cytometry on day 4 after the treatment (Day 4), or 3 days later (Day 7). Error bars: SEM. (<b>C</b>) β-galactosidase staining was performed in <i>Rplp1<sup>i</sup></i><sup>Δ</sup> and control pMEFs that were treated with 1 µM 4-OHT for 4 days or left untreated. (<b>D</b>) Quantification...
(A) Immunoblotting analysis of WT or mutant SVPs release. 293T cells transfected with the indicated ...
<p>(A) pRb was knocked down by siRNA in HEK293T cells subsequently transfected with NETs. Cell cycle...
<p>(A) Differentiation of EBs from normal (TIG-3) and WS (WSCU01 #02 and #13) iPSCs. Differentiated ...
<p><b>(A)</b> Replicative lifespans of <i>Chaos3</i> and WT primary MEFs. Cells were maintained unde...
<p>(A) NET4/TMEM53 knockdown with both siRNAs and the esiRNA all resulted in a reduced number of act...
<p>(A) Transfected 2BS cells containing pcDNA3.1, pcDNA-SIRT1 and pcDNA-H363YSIRT1 were lysated and ...
<p>MPA treated cells have increased SA-β-gal staining and higher senescence related p21<sup>WAF</sup...
Panel A shows the relative cell number after treatment with BPTES or 1% DMSO for 48 h following repe...
<p>(<b>A</b>) Western blot analysis of newly synthesized proteins in <i>Rplp1<sup>i</sup></i><sup>Δ<...
<p>Percentage of β- galactosidase positive cells was determined following radiation (<b>A</b>) and r...
<p>(A) Western blot analysis of <i>Rnf8<sup>−/−</sup>p53<sup>−/−</sup></i> and control MEFs for p21 ...
<p><b>(A)</b> RS treatment in primary <i>Trp53</i><sup><i>-/-</i></sup> MEFs upregulates senescence-...
<p>(A) Clonogenicity of <i>+/+</i> and <i>-/</i>- MEFs at P30. The asterisks represent significant d...
<p>(A) G1-S checkpoint analysis. <i>Rnf8<sup>−/−</sup>p53<sup>−/−</sup></i> early passage primary ME...
<p>(A) Mutations that abolish H4K16ac cause a reduction in H3K79me3 levels. Protein samples from asy...
(A) Immunoblotting analysis of WT or mutant SVPs release. 293T cells transfected with the indicated ...
<p>(A) pRb was knocked down by siRNA in HEK293T cells subsequently transfected with NETs. Cell cycle...
<p>(A) Differentiation of EBs from normal (TIG-3) and WS (WSCU01 #02 and #13) iPSCs. Differentiated ...
<p><b>(A)</b> Replicative lifespans of <i>Chaos3</i> and WT primary MEFs. Cells were maintained unde...
<p>(A) NET4/TMEM53 knockdown with both siRNAs and the esiRNA all resulted in a reduced number of act...
<p>(A) Transfected 2BS cells containing pcDNA3.1, pcDNA-SIRT1 and pcDNA-H363YSIRT1 were lysated and ...
<p>MPA treated cells have increased SA-β-gal staining and higher senescence related p21<sup>WAF</sup...
Panel A shows the relative cell number after treatment with BPTES or 1% DMSO for 48 h following repe...
<p>(<b>A</b>) Western blot analysis of newly synthesized proteins in <i>Rplp1<sup>i</sup></i><sup>Δ<...
<p>Percentage of β- galactosidase positive cells was determined following radiation (<b>A</b>) and r...
<p>(A) Western blot analysis of <i>Rnf8<sup>−/−</sup>p53<sup>−/−</sup></i> and control MEFs for p21 ...
<p><b>(A)</b> RS treatment in primary <i>Trp53</i><sup><i>-/-</i></sup> MEFs upregulates senescence-...
<p>(A) Clonogenicity of <i>+/+</i> and <i>-/</i>- MEFs at P30. The asterisks represent significant d...
<p>(A) G1-S checkpoint analysis. <i>Rnf8<sup>−/−</sup>p53<sup>−/−</sup></i> early passage primary ME...
<p>(A) Mutations that abolish H4K16ac cause a reduction in H3K79me3 levels. Protein samples from asy...
(A) Immunoblotting analysis of WT or mutant SVPs release. 293T cells transfected with the indicated ...
<p>(A) pRb was knocked down by siRNA in HEK293T cells subsequently transfected with NETs. Cell cycle...
<p>(A) Differentiation of EBs from normal (TIG-3) and WS (WSCU01 #02 and #13) iPSCs. Differentiated ...